Simpson-Yap, S. Et Al. 2022. Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β. Multiple Sclerosis and Related Disorders , vol.66 .

Simpson-Yap, S., Pirmani, A., De Brouwer, E., Peeters, L. M., Geys, L., Parciak, T., ... Helme, A.(2022). Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β. Multiple Sclerosis and Related Disorders , vol.66.

Simpson-Yap, Steve Et Al. "Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β," Multiple Sclerosis and Related Disorders , vol.66, 2022

Simpson-Yap, Steve Et Al. "Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β." Multiple Sclerosis and Related Disorders , vol.66, 2022

Simpson-Yap, S. Et Al. (2022) . "Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β." Multiple Sclerosis and Related Disorders , vol.66.

@article{article, author={Steve Simpson-Yap Et Al. }, title={Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β}, journal={Multiple Sclerosis and Related Disorders}, year=2022}